Anti-LPCAT4 monoclonal antibody

Pre-made anti-LPCAT4 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to LPCAT4/LPCAT4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1102-Ab-1/ GM-Tg-hg-IP1102-Ab-2Anti-Human LPCAT4 monoclonal antibodyHuman
GM-Tg-rg-IP1102-Ab-1/ GM-Tg-rg-IP1102-Ab-2Anti-Rat LPCAT4 monoclonal antibodyRat
GM-Tg-mg-IP1102-Ab-1/ GM-Tg-mg-IP1102-Ab-2Anti-Mouse LPCAT4 monoclonal antibodyMouse
GM-Tg-cynog-IP1102-Ab-1/ GM-Tg-cynog-IP1102-Ab-2Anti-Cynomolgus/ Rhesus macaque LPCAT4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1102-Ab-1/ GM-Tg-felg-IP1102-Ab-2Anti-Feline LPCAT4 monoclonal antibodyFeline
GM-Tg-cang-IP1102-Ab-1/ GM-Tg-cang-IP1102-Ab-2Anti-Canine LPCAT4 monoclonal antibodyCanine
GM-Tg-bovg-IP1102-Ab-1/ GM-Tg-bovg-IP1102-Ab-2Anti-Bovine LPCAT4 monoclonal antibodyBovine
GM-Tg-equg-IP1102-Ab-1/ GM-Tg-equg-IP1102-Ab-2Anti-Equine LPCAT4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1102-Ab-1/ GM-Tg-hg-IP1102-Ab-2; GM-Tg-rg-IP1102-Ab-1/ GM-Tg-rg-IP1102-Ab-2;
GM-Tg-mg-IP1102-Ab-1/ GM-Tg-mg-IP1102-Ab-2; GM-Tg-cynog-IP1102-Ab-1/ GM-Tg-cynog-IP1102-Ab-2;
GM-Tg-felg-IP1102-Ab-1/ GM-Tg-felg-IP1102-Ab-2; GM-Tg-cang-IP1102-Ab-1/ GM-Tg-cang-IP1102-Ab-2;
GM-Tg-bovg-IP1102-Ab-1/ GM-Tg-bovg-IP1102-Ab-2; GM-Tg-equg-IP1102-Ab-1/ GM-Tg-equg-IP1102-Ab-2
Products NameAnti-LPCAT4 monoclonal antibody
Formatmab
Target NameLPCAT4
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-LPCAT4 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1102-Ag-1Recombinant multi-species LPCT4/ LPCAT4/ AGPAT7 protein


    Target information

    Target IDGM-IP1102
    Target NameLPCAT4
    Gene ID254531,99010,296048,696388,478238,101090943,510842,100071891
    Gene Symbol and SynonymsAGPAT7,AYTL3,LPAAT-eta,LPCAT4,LPEAT2,LPLAT10,RGD1311177
    Uniprot AccessionQ643R3
    Uniprot Entry NameLPCT4_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000176454
    Target ClassificationN/A

    The target: LPCAT4, gene name: LPCAT4, also named as AGPAT7, AYTL3, LPAAT-eta, LPEAT2. Members of the 1-acylglycerol-3-phosphate O-acyltransferase (EC 2.3.1.51) family, such as AGPAT7, catalyze the conversion of lysophosphatidic acid (LPA) to phosphatidic acid (PA), a precursor in the biosynthesis of all glycerolipids. Both LPA and PA are involved in signal transduction (Ye et al., 2005 [PubMed 16243729]).[supplied by OMIM, May 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.